BAROZZI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 22.820
EU - Europa 9.099
AS - Asia 8.134
SA - Sud America 1.068
Continente sconosciuto - Info sul continente non disponibili 314
AF - Africa 189
OC - Oceania 10
Totale 41.634
Nazione #
US - Stati Uniti d'America 22.400
GB - Regno Unito 3.125
SG - Singapore 2.269
CN - Cina 2.265
IT - Italia 1.975
HK - Hong Kong 1.083
SE - Svezia 913
VN - Vietnam 824
BR - Brasile 802
DE - Germania 678
FI - Finlandia 587
RU - Federazione Russa 400
UA - Ucraina 400
FR - Francia 366
BD - Bangladesh 350
TR - Turchia 329
KR - Corea 224
IN - India 220
CA - Canada 211
BG - Bulgaria 153
NL - Olanda 107
ID - Indonesia 95
AR - Argentina 86
MX - Messico 81
JP - Giappone 68
IQ - Iraq 57
BE - Belgio 50
ZA - Sudafrica 48
ES - Italia 46
PL - Polonia 45
AE - Emirati Arabi Uniti 43
CO - Colombia 42
EC - Ecuador 41
CZ - Repubblica Ceca 40
IE - Irlanda 40
IR - Iran 38
CL - Cile 32
LT - Lituania 31
PK - Pakistan 31
PH - Filippine 30
AT - Austria 29
BZ - Belize 26
MA - Marocco 24
VE - Venezuela 24
CR - Costa Rica 23
UZ - Uzbekistan 23
KE - Kenya 22
MY - Malesia 22
AZ - Azerbaigian 21
JM - Giamaica 21
EG - Egitto 18
RO - Romania 18
PY - Paraguay 17
TN - Tunisia 17
DZ - Algeria 16
EU - Europa 16
SA - Arabia Saudita 16
IL - Israele 14
JO - Giordania 14
NP - Nepal 12
CY - Cipro 11
DK - Danimarca 10
TH - Thailandia 10
TW - Taiwan 10
AU - Australia 9
CH - Svizzera 9
ET - Etiopia 9
HN - Honduras 9
NI - Nicaragua 9
PT - Portogallo 9
SK - Slovacchia (Repubblica Slovacca) 9
UY - Uruguay 9
AL - Albania 8
PE - Perù 8
EE - Estonia 7
PS - Palestinian Territory 7
RS - Serbia 7
SV - El Salvador 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
GR - Grecia 6
KZ - Kazakistan 6
QA - Qatar 6
KG - Kirghizistan 5
MD - Moldavia 5
NG - Nigeria 5
OM - Oman 5
PA - Panama 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
AM - Armenia 4
BB - Barbados 4
BY - Bielorussia 4
GT - Guatemala 4
LB - Libano 4
LV - Lettonia 4
PR - Porto Rico 4
SC - Seychelles 4
SI - Slovenia 4
BA - Bosnia-Erzegovina 3
Totale 41.279
Città #
Ashburn 2.652
Southend 2.310
Fairfield 1.978
Santa Clara 1.649
Singapore 1.442
Woodbridge 1.279
Hong Kong 1.070
Houston 960
Chandler 956
San Jose 871
Ann Arbor 820
Jacksonville 787
Hefei 771
Seattle 742
Wilmington 698
Dearborn 655
Council Bluffs 609
Cambridge 590
Nyköping 504
Helsinki 417
Los Angeles 405
Chicago 386
Beijing 385
London 384
New York 338
Modena 299
Ho Chi Minh City 275
The Dalles 270
Milan 210
Seoul 205
Izmir 190
Buffalo 180
Hanoi 178
San Diego 166
Princeton 149
Sofia 149
Eugene 139
Dallas 131
Salt Lake City 131
Lauterbourg 119
Moscow 107
Munich 107
São Paulo 97
Columbus 95
Rome 92
Fremont 89
Boardman 84
Shanghai 77
Bremen 71
Des Moines 71
Phoenix 69
Bologna 68
Tampa 65
Atlanta 57
Elk Grove Village 57
Orem 56
Jakarta 54
Tokyo 53
Frankfurt am Main 52
Toronto 51
Brooklyn 49
Redwood City 48
Montreal 44
Da Nang 42
Philadelphia 42
Brussels 41
Haiphong 39
Dublin 37
Chennai 35
Albuquerque 34
Boston 34
Denver 34
Lancaster 33
Naples 32
Miami 31
Turku 31
Las Vegas 29
North Bergen 29
Kent 28
Johannesburg 27
Ottawa 27
Paris 27
San Francisco 27
Warsaw 27
Belize City 26
Washington 26
Miano 25
Rio de Janeiro 25
Verona 25
Reggio Emilia 24
Stockholm 24
Guangzhou 23
Mexico City 23
Nanjing 23
Norwalk 23
Baghdad 22
Tashkent 22
Amsterdam 21
Leawood 21
Newark 21
Totale 29.122
Nome #
HHV-6A in syncytial giant-cell hepatitis 486
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 486
B cells and herpesviruses: a model of lymphoproliferation 475
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 459
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 455
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 442
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 423
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 420
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 410
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 402
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 401
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 392
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 388
Mucorales-specific T cells in patients with hematologic malignancies 386
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 386
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 382
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 380
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 375
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 374
Translational challenges of human herpesvirus 6 chromosomal integration. 373
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 373
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 373
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 371
Acute appendicitis in adult neutropenic patients with hematologic malignancies 367
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 366
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 365
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 365
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 361
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 359
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 359
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 353
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 345
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 340
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 338
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 337
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 332
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 330
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 328
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 328
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 327
Parvoviruses in blood donors and transplant patients, Italy 326
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 325
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 323
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 322
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 322
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 321
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 319
Diagnosis of aspergillosis: Role of proteomics 318
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 316
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 315
HHV-8 infection in the transplantation setting: A concern only for solid organ transplant patients? 313
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 302
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 302
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 301
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 300
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 298
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 296
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 296
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 295
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 294
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 292
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 292
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 291
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 287
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 284
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 282
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 281
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 278
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 277
How I treat HHV8/KSHV-related diseases in posttransplant patients. 275
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 275
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 274
Late-appearing PML/RAR alpha fusion transcript with coincidental t(12;13)(p13.2;q14) in acute promyelocytic leukemia lacking the t(15;17) cytogenetic anomaly 273
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 271
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 269
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 267
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 266
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 264
Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients 260
HUMAN HERPESVIRUS-6 - A SURVEY OF PRESENCE AND DISTRIBUTION OF GENOMIC SEQUENCES IN NORMAL BRAIN AND NEUROGLIAL TUMORS 260
Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission 256
Human herpesvirus-8 infection in hemodialysis patients from northern Italy. 255
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 254
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 253
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patients 252
Neither Human Herpesvirus 8 nor a related variant could be detected in bone marrow stromal cells from multiple myeloma patients. 251
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 249
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia 248
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 248
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 245
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation 245
Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease 240
Human herpesvirus-6 (HHV-6) in blood donors 237
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 235
Human herpesvirus 6 infection in normal human brain tissue 235
Hepatitis C virus-induced leuko-thrombocytopenia and haemolysis 232
Age- and sex-specific seroprevalence of human herpesvirus 8 in Jamaica - Response 232
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 232
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 231
Polymerase chain reaction detection of human herpesvirus 8 sequences in primary central nervous system lymphomas 229
Totale 31.893
Categoria #
all - tutte 158.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.940


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.922 0 0 0 171 57 98 181 136 264 189 505 321
2022/20232.915 391 322 173 284 429 388 75 277 298 36 148 94
2023/20241.938 66 110 137 167 410 206 218 284 35 38 85 182
2024/20255.820 248 71 101 426 1.053 832 454 324 609 240 617 845
2025/202611.428 814 507 1.072 1.219 1.812 877 1.346 564 1.110 949 716 442
2026/20272.958 340 690 870 1.058 0 0 0 0 0 0 0 0
Totale 41.634